Stay updated with breaking news from Nasdaq Ctic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CTI BioPharma (NASDAQ:CTIC – Get Rating) was downgraded by equities researchers at Needham & Company LLC from a “buy” rating to a “hold” rating in a report issued on Wednesday, The Fly reports. Other equities analysts also recently issued reports about the stock. JMP Securities restated a “market outperform” rating and set a $9.00 target […]
SG Americas Securities LLC lessened its position in shares of CTI BioPharma Corp. (NASDAQ:CTIC – Get Rating) by 4.9% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 49,149 shares of the biopharmaceutical company’s stock after selling 2,555 shares during the quarter. SG Americas Securities […]
CTI BioPharma Corp. (NASDAQ:CTIC – Get Rating) has been assigned an average rating of “Moderate Buy” from the eight ratings firms that are covering the stock, Marketbeat.com reports. One analyst has rated the stock with a hold rating and seven have issued a buy rating on the company. The average 12 month price objective among […]
Shares of CTI BioPharma Corp. (NASDAQ:CTIC – Get Rating) have been assigned a consensus rating of “Moderate Buy” from the eight ratings firms that are covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a hold rating and seven have issued a buy rating on the company. The average 1 […]
CTI BioPharma (NASDAQ:CTIC – Get Rating) had its price objective lowered by TD Cowen from $10.00 to $8.00 in a research note released on Monday, Benzinga reports. The firm currently has an outperform rating on the biopharmaceutical company’s stock. A number of other brokerages have also weighed in on CTIC. StockNews.com raised CTI BioPharma from […]